Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

$12+ Billion Influenza Vaccines Market to Grow at 7+% CAGR, Globally, by 2028 Lead by Quadrivalent Vaccines Segment with 88.36% Market Share in 2022 | The Insight Partners

This image opens in the lightbox

News provided by

The Insight Partners

28 Oct, 2022, 10:30 GMT

Share this article

Share toX

Share this article

Share toX

NEW YORK, Oct. 28, 2022 /PRNewswire/ -- The Insight Partners published latest research study on "Influenza Vaccines Market Size, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028 – COVID-19 Impact and Global Analysis – by Vaccine Type, Virus Type, Technology, Route of Administration, Target Group, and Geography," the global influenza vaccines market size reached from USD 7.47 billion in 2021 to USD 12.27 billion by 2028; it is expected to grow at a CAGR of 7.4% from 2022 to 2028. Increased government support to promote influenza vaccination and a rise in investment by top market players and governments worldwide are driving the market. However, the high cost of vaccine development is hampering the market's growth.

Download Sample PDF Brochure of Influenza Vaccines Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at: https://www.theinsightpartners.com/sample/TIPRE00004070/

Global Influenza Vaccines Market Report Scope, Segmentations, Regional & Country Scope:

Report Coverage

Details

Market Size Value in

USD 7.47 Billion in 2021

Market Size Value by

USD 12.27 Billion by 2028

Growth rate

CAGR of 7.4% from 2022 to 2028

Forecast Period

2022-2028

Base Year

2021

No. of Pages

209

No. of Tables

138

No. of Charts & Figures

80

Historical data available

Yes

Segments covered

Vaccine Type, Virus Type, Technology, Route of Administration, and Target Group

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Companies Covered

Moderna, Inc.; SEQIRUS; Sanofi; GlaxoSmithKline plc; Hualan Biological Engineering Inc.; Emergent BioSolutions Inc.; Mitsubishi Chemical Group Corporation; Serum Institute of India Pvt. Ltd; Mylan N. V.; AstraZeneca

Key Research Capabilities

Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development

Global Influenza Vaccines Market Forecast to 2028 - Latest COVID-19 Analysis

https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00004070/

Browse key market insights spread across 209 pages with 138 list of tables & 80 list of figures from the report, "Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly)" in detail along with the table of contents: https://www.theinsightpartners.com/reports/influenza-vaccines-market

Global Influenza Vaccines Market: Competition Landscape and Key Developments

Moderna, Inc.; SEQIRUS; Sanofi; GlaxoSmithKline plc; Hualan Biological Engineering Inc.; Emergent BioSolutions Inc.; Mitsubishi Chemical Group Corporation; Serum Institute of India Pvt. Ltd; Mylan N. V.; and AstraZeneca are the key companies operating in the influenza vaccines market. The companies are taking up product innovation strategies to meet the evolving customer demands globally, allowing them to maintain their brand name in the global influenza vaccines market. A few of the recent developments in the influenza vaccines market are mentioned below:

In July 2022, GSK announced an agreement with the Government of Canada for pandemic and seasonal influenza vaccines to help protect Canadian adults and children. The 4-year agreement, spanning through March 2026, includes the supply of as many as 80 million doses of Arepanrix (adjuvanted pandemic influenza vaccine) in the event of an influenza pandemic(s) and a minimum of 4 million doses per year of Flulaval Tetra (seasonal influenza vaccine).

In July 2022, The US Food and Drug Administration (US FDA) approved Sanofi's licensure request for vaccine approval for the upcoming 2022-2023 flu season, including Fluzone High-Dose Quadrivalent (Influenza Vaccine), Flublok Quadrivalent (Influenza Vaccine), and Fluzone Quadrivalent (Influenza Vaccine). This approval comes on the heels of the CDC's Advisory Committee on Immunization Practices (ACIP) preferential recommendation for adults 65+ including Fluzone High-Dose Quadrivalent and Flublok Quadrivalent.

In June 2022, Moderna, Inc. announced the first participants had been dosed in a Phase 3 study of the Company's seasonal influenza vaccine candidate (mRNA-1010). The trial is expected to enroll approximately 6,000 adults from countries in Southern Hemisphere.

Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPRE00004070/

The influenza virus causes flu, a contagious respiratory illness that infects the nose, throat, and lungs. It can be mild or severe and sometimes may lead to death. Flu vaccination every year can help in preventing flu. However, this can be deadly, especially in high-risk groups. The aged population, pregnant women, and people with one or more chronic diseases or weak immune systems are at high risk. Influenza vaccines/flu shots protect against the 4 influenza virus subtypes that are most common. Most influenza vaccines are "flu shots" given with a needle, usually in the arm, but nasal spray flu vaccines are also available.

Increase in Government Support to Promote Influenza Vaccination to Drive Global Influenza Vaccines Market:

The governing bodies of various states and countries are supporting the promotion of vaccination through multiple activities and programs. For instance, the National Immunization Program (NIP) gives the Australian government a free seasonal influenza vaccine to those at risk of influenza-related complications. By 2022, enough vaccines would be secured to cover all risk groups eligible for a government-funded flu vaccine through the NIP. Below are a few more instances supporting the government support for influenza vaccination:

In July 2022, Public Services and Procurement Minister Filomena Tassi and Health Minister Jean-Yves Duclos announced that the Government of Canada had signed a new contract with GlaxoSmithKline (GSK) to support a sustainable influenza pandemic readiness. The Government of Canada maintains pandemic influenza vaccine preparedness in the event of an influenza pandemic. It has a contract in place with GSK to provide seasonal and pandemic influenza vaccines since 2001. Pandemic influenzas are unpredictable but occur when a new strain of influenza virus emerges, spreads widely, and causes the disease.

In July 2022, Seniors and Long-term Care Minister Scott Johnston and Health Minister Audrey Gordon announced that the Manitoba government would expand the high-dose flu vaccine eligibility to include all adults aged 65 and over to ensure more Manitoba people are protected against influenza.

Speak to Research Expert: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00004070

The Victorian government proposed a grant and reimbursement program to help GPs and pharmacies improve access and uptake of the influenza vaccines by June and July 2022.

In June 2022, The New Zealand government expanded the access to free flu vaccines, with an additional 800,000 New Zealanders eligible from July 1, 2022. Children aged 3 to 12 years and people with severe mental health or addiction problems can now get a free dose of the flu vaccines.

Taiwan's Centers for Disease Control (Taiwan CDC), and the Ministry of Health and Welfare, organized a media event, titled "Let's Stay Healthy Together" to kick off the 2021 government-funded influenza vaccination program. At the event, Director General Chou, Ambassador Tan, and Hsin Chiang were the first to be vaccinated to encourage eligible people to receive government-funded flu vaccines to get their flu vaccinations as soon as possible following the program.

In September 2019, US President Donald Trump signed an executive order to promote the development of better vaccines to protect against seasonal flu and the potential for pandemic flu outbreaks.

In Oct 2021, with flu season approaching, the Provincial Government was encouraging all Newfoundlanders and Labradorians to get a flu shot in the year 2021. Starting October 25, 2021, the Regional Health Authorities (RHAs) have begun hosting free flu vaccination clinics. People can also get the vaccine through their family doctor or local pharmacy.

The increasing government support to promote vaccination worldwide is driving the influenza vaccine market. The influenza vaccines market includes many small and big companies. Market players are adopting various strategies to increase their market shares; these include new product launches, regional expansion, and technological advancements.

Quickly Purchase Premium Copy of Influenza Vaccines Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00004070/

Go through further research published by The Insight Partners:

Travel and Expense Management Software Market - The global travel and expense management software market size is projected to grow from US$ 3,320.02 million in 2022 & it is estimated to grow at a CAGR of 8.0% from 2022 to 2028.

Left Ventricular Assist Device Market - The global left ventricular assist device market size was expected to reach US$ 1,272.08 million in 2021 & it is expected to grow at a CAGR of 5.1% from 2022 to 2028.

Medical Device Coating Market - The global medical device coating market size was expected to reach US$ 7,644.09 million in 2021 and it is estimated to grow at a CAGR of 7.7% from 2022 to 2028.

Railway Cybersecurity Market - The global railway cybersecurity market size is projected to grow from US$ 7,469.51 million in 2022 & it is estimated to grow at a CAGR of 10.7% from 2022 to 2028.

Overactive Bladder Treatment Market - The global overactive bladder treatment market size is expected to grow from US$ 4,295.93 million in 2021 & It is estimated to grow at a CAGR of 3.1% from 2022 to 2028.

Lipidomics Equipment Market – The global lipidomics equipment market size was valued at US$ 1,025.38 million in 2021 and it is expected to grow at a CAGR of 14.7% from 2022 to 2028.

Spiral Membrane Market – The global spiral membrane market size is expected to grow from US$ 7.6 billion in 2022 to US$ 14.2 billion in 2028 with an estimated CAGR of 10.9% from 2022 to 2028.    

Thermal Interface Materials Market - The global thermal interface materials market size is expected to grow from US$ 2.9 billion in 2021 to US$ 6.5 billion by 2028 at a CAGR of 11.3% between 2022 and 2028.

High Purity Alumina Market - The global high purity alumina market size is expected to grow from US$ 2.1 billion in 2021 to US$ 5.5 billion by 2028 at a CAGR of 15.1% between 2022 and 2028.

Battery Separators Market - The global battery separators market size is expected to grow from US$ 5.6 billion in 2022 to US$ 9.5 billion by 2028; it is estimated to grow at a CAGR of 9.0% between 2022 and 2028.

Automotive Foam Market – The global automotive foam market size is expected to grow from US$ 56.6 billion in 2021 to US$ 109.5 billion by 2028 at a CAGR of 9.3% between 2022 and 2028.

Wind Energy Market - The global wind energy market size is expected to grow from US$ US$ 156.8 billion in 2021 and it is anticipated to grow at a CAGR of 5.0% from 2022 to 2028.

Maritime Information Market - The global maritime information market size was valued at US$ 1,882.01 million in 2021 and it is expected to grow at a CAGR of 6.2% from 2022 to 2028.

Print Management Software Market - The global print management software market size is projected to grow from US$ 2,000.99 million in 2022, it is estimated to grow at a CAGR of 15.2% from 2022 to 2028.

Diabetes Therapeutics Market - The global diabetes therapeutic market size is expected to grow from USD 58.46 billion in 2021 to USD 91.73 billion by 2028, with an estimated CAGR of 6.8% from 2022 to 2028.

LED Lighting Market - The global LED lighting market size is expected to grow from US$ 57.5 billion in 2021 and it is expected to grow at a CAGR of 10.7% from 2022 to 2028.

Molded Interconnect Devices Market - The global molded interconnect device (MID) market size is expected to grow from US$ 1,203.5 million in 2021 to US$ 2,711.9 million by 2028 at a CAGR of 14.5% from 2022 to 2028.

Digital Education Market - The global digital education market size is expected to grow from US$ 11.62 billion in 2021 to US$ 54.95 billion by 2028 at a CAGR of 26.1% between 2022 and 2028.

Biometric System Market - The global biometric system market size is expected to grow from US$ 43 billion in 2021 to US$ 85 billion by 2028 at a CAGR of 14.5% between 2022 and 2028.

Wifi-as-a-Service Market - The global wi-fi as a service market size is projected to grow from US$ 3.66 billion in 2021 to US$ 13.34 billion by 2028; it is expected to grow at a CAGR of 19.5% during 2022–2028.

Sound Recognition Market - The global sound recognition market size is projected to grow from US$ 3.84 billion in 2021 to US$ 9.70 billion by 2028; it is expected to grow at a CAGR of 14.5% from 2022 to 2028.

Network Transformation Market - The global network transformation market size is expected to grow from US$ 19.27 billion in 2021 to US$ 175.34 billion by 2028 at a CAGR of 40.6% between 2022 and 2028.

Molded Interconnect Devices (MID) Market - The global molded interconnect device (MID) market size is expected to grow from US$ 1,203.5 million in 2021 to US$ 2,711.9 million by 2028 at a CAGR of 14.5% from 2022 to 2028.

Data Collection and Labeling Market - The global data collection and labeling market size is expected to grow from US$ 1.82 billion in 2021 to US$ 9.07 billion by 2028 at a CAGR of 27.2% between 2022 and 2028.

Customer Data Platform Market - The global customer data platform market size is expected to grow from US$ 2,672.5 Mn in 2021 to US$ 14,847.1 Mn by 2028 at a CAGR of 28.2% between 2022 and 2028.

Vehicle Tracking Systems Market - The global vehicle tracking systems market size is expected to grow from US$ 13.67 billion in 2021 to US$ 23.70 billion by 2028; it is expected to grow at a CAGR of 8.7% from 2022 to 2028.

Autonomous Last Mile Delivery Market - The global autonomous last mile delivery market size is expected to grow from US$ 57.67 billion in 2021 to US$ 68.95 billion by 2028; it is expected to register a CAGR of 3.0% from 2022 to 2028.

ISDN Modem Market - The global ISDN modem market size was valued US$ 982.97 thousand in 2022, it is estimated to register a CAGR of -80.6% from 2022 to 2024.

Semiconductor Bonding Market - The global semiconductor bonding market size was valued US$ 669.48 million in 2022, it is estimated to grow at a CAGR of 8.2% from 2022 to 2028.

Recycled Ocean Plastics Market - The global recycled ocean plastics market size was valued at US$ 14,432.91 million in 2022, it is expected to grow at a CAGR of 8.5% from 2022 to 2028.

EDM Wire Market - The global EDM wire market size is expected to grow from US$ 1,497.50 million in 2022, it is estimated to grow at a CAGR of 7.6% from 2022 to 2028.

Seam Welding Machine Market - The global seam welding machine market size was valued US$ 1,142.87 million in 2022, it is estimated to grow at a CAGR of 4.0% from 2022 to 2028.

Electric Coolant Pump Market - The global electric coolant pump market size was valued US$ 467.46 million in 2022, it is estimated to grow at a CAGR of 16.8% from 2022 to 2028.

Smart Manufacturing Market - The global smart manufacturing market size was valued US$ 258.72 billion in 2022, it is estimated to grow at a CAGR of 6.0% from 2022 to 2028.

.Respiratory Care Devices Market - The global respiratory care devices market size is expected to grow from US$ 18,114.31 million in 2021 to US$ 32,761.82 million by 2028; it is estimated to register a CAGR of 8.9% from 2021 to 2028.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/influenza-vaccines-market

Logo: https://mma.prnewswire.com/media/1586348/The_Insight_Partners_Logo.jpg 

Modal title

Also from this source

eSIM Market Size is Set to Achieve USD 17.98 Billion by 2031, With CAGR of 18.7% | The Insight Partners

eSIM Market Size is Set to Achieve USD 17.98 Billion by 2031, With CAGR of 18.7% | The Insight Partners

According to a new comprehensive report from The Insight Partners, the global eSIM market is observing significant growth owing to the rising...

HR Analytics Market Size to Surpass USD 9.89 Billion CAGR of 14.9% during 2025-2031

HR Analytics Market Size to Surpass USD 9.89 Billion CAGR of 14.9% during 2025-2031

According to a new comprehensive report from The Insight Partners, the global HR analytics market is observing significant growth owing to the...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.